Headquartered in Saratoga, CA with subsidiaries in Bangalore, and Australia, Bugworks Research announced that the first human dose was administered in a phase 1 clinical trial. This trial to evaluate BWC0977, a next generation broad-spectrum, novel bacterial topoisomerase inhibitor (NBTI), was supported by Boston University's CARB-X -- Combating Antibiotic-Resistant Bacteria...
Sanmina Expects to Manufacture Medical Devices in India
San Jose, CA-based Sanmina Corporation received FDA registration at its Chennai, India manufacturing facilities. The registration allows for the company to manufacture finished products like imaging systems, blood glucose meters, patient monitors and other complex medical instruments and devices. Sanmina becomes the first tier 1 Electronic Manufacturing Services company to...
Abbott Labs Leads the Way in India Pharmaceutical Market
India is one of the fastest growing pharmaceutical markets in the world generating almost $8 billion per year. That amount is more than expected to double by 2015 with annual growth from 15 to 20 percent. Following the acquisition of India's pharma leader Ranbaxy Labs by a Japanese company, the...